Pliant Therapeutics
PLRX
$15.27
Share price
-2.18%
Change (1 day)
-29.08%
Change (1 year)
Categories
Pliant Therapeutics (PLRX) - Cash on Hand
Cash on Hand as of December 2023 : $0.49 B
According to Pliant Therapeutics's latest financial reports the company has $0.49 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Pliant Therapeutics - Cash on Hand chart (from 2019 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $0.49 B | 49.23% |
| 2022-12-31 | $0.33 B | 65.1% |
| 2021-12-31 | $0.20 B | -27.55% |
| 2020-12-31 | $0.27 B | 169.42% |
| 2019-12-31 | $0.10 B | 68.62% |
| 2018-12-31 | $60.94 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 OPKO Health
OPK | $95.88 M | -80.60% | 🇺🇸 USA |
 Onconova Therapeutics ONTX | $20.82 M | -95.79% | 🇺🇸 USA |